5-NITRO-3-(TRIFLUOROMETHYL)-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 100mg

(2E)-1-{[1,1'-biphenyl]-4-yl}-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

(4-Bromonaphthalen-1-yl)boronic acid, 95.0%, 1g

Dialysis membrane Spectra/Por® 1 to 4 Spectra/Por® 1 - MWCO 6000 to 8000, 120 mm, 15 m, 1 Piece(s)

3-(2,4-Difluorophenyl)-propionic acid, 98.0%, 100g

(S)-2-((S)-2-AMINO-3-METHYLBUTANAMIDO)-5-UREIDOPENTANOIC ACID, 95%, 100mg

3-(4-Nitrophenyl)-3-oxopropanenitrile, 95.0%, 100mg

4-AMINO-1-METHYL-1H-PYRAZOLE-3-CARBONITRILE, 95.0%, 5g

But-3-en-1-ylboronic acid, 98%, 250mg

4-Bromo-2,6-difluorophenol, 97.0%, 5g

2-Amino-N-methyl-acetamide hydrochloride, 95.0%, 1g

4-Phenylbenzoylacetonitrile, 97.0%, 2g

2-(5-Fluoro-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 1g